Fasoracetam is a research chemical of the racetam family. It is a putative nootropic that failed to show sufficient efficacy in clinical trials for vascular dementia. It is currently being studied for its potential use for attention deficit hyperactivity disorder.
| Product Name: | FASORACETAM |
| Synonyms: | (R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one;NS 105 (pharmaceutical);(R)-1-[(5-Oxo-2-pyrrolidinyl)carbonyl]piperidine;Fasoracetam,NS-105,LAM-105;(5R)-5-(哌啶-1-羰基)吡咯烷-2-酮;FASORACETAM;(5R)-5-(piperidine-1-carbonyl)-2-pyrrolidone;(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one |
| CAS: | 110958-19-5 |
| MF: | C10H16N2O2 |
| MW: | 196.248 |
| EINECS: | 1592732-453-0 |